Join us for AMP 2022 Workshop on surveillance and epidemiology of Severe Acute Respiratory pathogens Date: Wednesday, November 2, 2022 Time: 11:00 AM- 11:50 AM MST Room: 228AB Speaker: Dr. Anna Strain, Ph.D Infectious Disease Laboratory, Minnesota Department of Health…
The 2022 AACC Clinical Lab Expo is the premier global laboratory medicine exposition. Come meet with the Seegene team (Booth # 2261) to learn about our molecular testing solutions. Seegene's COVID-19 EUA and various Research Use molecular assays are designed…
Published on: PR Newswire SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the…
Attend the 2022 APHL Annual Conference, a hybrid event for the public health laboratory (PHL) community. Come meet with the Seegene Technologies team (BOOTH# 500) to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy…
Join us for NILA's first "live" meeting in over 2 years! Come meet with the Seegene Technologies team to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets with high accuracy for infectious diseases, respiratory infections, and…
Throughout the COVID-19 pandemic, identifying individuals who have been infected with SARS-CoV-2 in a reliable and timely manner has been a crucial strategy in controlling the spread of the disease. Over the course of the last two years, several at-home…
Published on: PR Newswire Dr. Hansen to provide clinical input to the product development process; strengthen strategic partnerships with U.S. networks SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM),…
2022 ASM Clinical Virology Symposium We are looking forward to meeting you at ASM CVS! The Seegene Technologies team will be set up at Booth 622, so come by to learn about our molecular diagnostic solutions that can simultaneously detect multiple targets…
Published on: PR Newswire Dr. Creager to lead U.S. business from R&D, local production to M&A: "Thrilled to create synergy to help Seegene grow as a top global molecular diagnostics company through success in U.S." SEOUL, South Korea, March 2, 2022 /PRNewswire/…
Published on Korea Biomedical Review Seegene, a multiplex molecular diagnostics company, said that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes. Seegene's new product, Allplex SARS-CoV-2 fast MDx Assay, has obtained the Conformity…
After the global spikes in positive Omicron variant cases in December 2021 and January 2022, February saw a dip in the number of COVID-19 cases and deaths worldwide. In addition to this, several US states have lifted mask mandates. Large…
Driving Innovation and Collaboration in Diagnostics and Precision Medicine We are looking forward to meeting you at Molecular Med Tri-Con!The Seegene Technologies team will be set up at Booth 510, so come by to learn about our molecular diagnostic solutions that…
Although the “original” BA.1 subvariant of Omicron is the dominant form of the SARS-CoV-2 variant worldwide, a subvariant, BA.2 is now spreading rapidly in Asia and in parts of Europe and is reported to be the dominant form of SARS-CoV-2…
In 2020, the news broke that the Pfizer and Moderna SARS-CoV-2 vaccines had reached historic milestones. This began the conversation about a roll-out plan and how our lives would be impacted moving forward. At that point in time, many schools…